The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNottingham University Hospitals NHS Trust

About this trial

The goal of this qualitative study is to explore the impact of antiviral treatment, or none, for chronic hepatitis B virus on the non-clinical (social) harms experienced by migrant populations living in the UK.

Two groups of participants living with hepatitis B virus will be interviewed, those taking the daily treatment, and those not prescribed any treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Chronic HBsAg

Able to give informed consent in English

Able to converse in English

Any migrant population member (non-UK) including if born overseas or in the UK

Disqualifiers

Emotionally distressed due to HBV diagnosis

Current episode of decompensated cirrhosis

Current diagnosis of hepatocellular carcinoma

Trial population

Adults living with chronic hepatitis B virus infection

Trial design

Design model

Other

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

30 Participants
are grouped into 1 trial group
Group A: HBsAg positive

Trial outcomes

Primary outcomes

1

The qualitative Interview Topic Guide Questionnaire will thematically measure patients' experience of treatment, or not having treatment, for chronic hepatitis B virus infection.

A qualitative interview topic guide questionnaire on patient's experience of treatment, or no treatment, for hepatitis B virus infection. The coding scheme will be inductively derived by the study team and overarching themes that characterise patients' experiences will be determined.

Time frame
The outcome measure will be assessed and data collected for reporting on day 1

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: